June 12 & 13, 2013, University of Pennsylvania Campus, Chemistry Bldg, Philadelphia PA
Presentations*:
Wednesday, June 12, 2013
- 9:05 am - The Case for Change: A New Paradigm for Precompetitive Collaborations
Christopher Welch, Merck Research Laboratories
Jean Tom, Bristol-Myers Squibb
Joel M. Hawkins, Pfizer - 10:15 am - Panel Discussion 1: Cross-Pharma Collaborations
- Margaret Faul, Amgen
- Chris Hill, Merck Research Laboratories
- Steve King, AbbVie Research & Development
- Chris Senanayake, Boehringer-Ingelheim
- Chris Sinko, Bristol-Myers Squibb
- Gerry Taber, Pfizer
- 1:00 pm - Case Studies in Funded External Collaborations
- 1:30 pm - Academic Collaborations with Pharma: Past, Present, Future?
- 2:00 pm - Panel Discussion 2: Vendor and Supplier Collaboration with Pharma
- 3:15 pm - The Role of Government Labs in Facilitating Multi-Party Collaboration
Mike Tarlov, National Institute of Standards and Technology - 3:45 pm - Role of Academic Science and Technology Centers in Developing Enabling Technologies
- 4:15 pm - The Mission of CCR: Facilitating Collaboration in Chemistry & Chemical Engineering
Marc Donohue, Johns Hopkins University & 2013 CCR Chair
Paul Mendez, CCR - 4:45 pm - Preview of Next Day’s Breakouts
Thursday, June 13, 2013
- 8:30 am - Benefits of Cross-Pharma Collaboration on Enabling Technologies
Jacquelyn Gervay-Hague, University of California-Davis, (Director, Division of Chemistry at National Science Foundation, effective July 2013) - 9:00 am Successful Negotiations of Research Collaboration Agreements
- Kim Folander, Merck Research Laboratories
- Trude Amick, University of Pennsylvania
- 9:30 am Parallel Break-Out Sessions
Session A – Streamlining Agreements for External Research Collaborations
Session B – Working with Government Laboratories
Session C – Defining the “Edges” of Precompetitive Collaboration - 10:30 am - Report Out from Breakout Sessions
- 12:00 - Workshop Summary & Next Steps
* Not all presentations available to post publicly